Catalyst Wire Dossier Catalyst Wire Dossier

Sodium Oxybate (Xyrem)

Sodium Oxybate · Hikma Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sodium Oxybate (Xyrem), covering 2022-08-22 to 2022-08-22. Get the full timeline:

Most recent: FDA Approved: SODIUM OXYBATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

See pricing